Vanguard Group Inc Cytosorbents Corp Call Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CTSO
# of Institutions
58Shares Held
17.1MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$2.67 Million0.21% of portfolio
-
Skylands Capital, LLC2.76MShares$2.48 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$2.4 Million0.08% of portfolio
-
Sargent Investment Group, LLC1.63MShares$1.46 Million0.45% of portfolio
-
Neuberger Berman Group LLC New York, NY1.54MShares$1.38 Million0.0% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $39.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...